David Quigley

About David Quigley

David Quigley, With an exceptional h-index of 33 and a recent h-index of 26 (since 2020), a distinguished researcher at University of California, San Francisco, specializes in the field of Genetics, Cancer Biology, Bioinformatics, Genomics, Prostate Cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Contribution of cancer associated fibroblasts to treatment response and resistance in high-risk multifocal prostate cancer

Single cell-transcriptomic analysis informs the lncRNA landscape in metastatic castration resistant prostate cancer

Advancing the drug development process in metastatic prostate cancer through machine learning.

Abstract LB196: An atlas of accessible chromatin in advanced prostate cancer

Somatostatin receptor 1 (SSTR1) expression as a potential predictive biomarker for response to androgen receptor signaling inhibitor (ARSI) therapy in metastatic …

Transcriptomic heterogeneity of expansile cribriform and other Gleason Pattern 4 prostate cancer subtypes

Association of a prostate cancer gastrointestinal transcriptional phenotype as found in clinical mCRPC samples with response to AR-targeted therapy.

Gene networks reveal stem-cell state convergence during preneoplasia and progression to malignancy in multistage skin carcinogenesis

David Quigley Information

University

Position

___

Citations(all)

4277

Citations(since 2020)

3135

Cited By

2284

hIndex(all)

33

hIndex(since 2020)

26

i10Index(all)

57

i10Index(since 2020)

48

Email

University Profile Page

Google Scholar

David Quigley Skills & Research Interests

Genetics

Cancer Biology

Bioinformatics

Genomics

Prostate Cancer

Top articles of David Quigley

Title

Journal

Author(s)

Publication Date

Contribution of cancer associated fibroblasts to treatment response and resistance in high-risk multifocal prostate cancer

Cancer Research

Nikolett Lupsa

Erika Heninger

Adeline Ding

Shannon R Reese

Xavier T Hazelberg

...

2024/3/22

Single cell-transcriptomic analysis informs the lncRNA landscape in metastatic castration resistant prostate cancer

NPJ Genomic Medicine

Debanjan Saha

Ha X Dang

Meng Zhang

David A Quigley

Felix Y Feng

...

2024/2/23

Advancing the drug development process in metastatic prostate cancer through machine learning.

David Alan Quigley

Julian C Hong

Nicholas Lillis

Ali Sabbagh

Isabel D Friesner

...

2024/2/1

Abstract LB196: An atlas of accessible chromatin in advanced prostate cancer

Cancer Research

Raunak Shrestha

Lisa N Chesner

Meng Zhang

Stanley Zhou

Adam Foye

...

2024/4/1

Somatostatin receptor 1 (SSTR1) expression as a potential predictive biomarker for response to androgen receptor signaling inhibitor (ARSI) therapy in metastatic …

Xiaolin Zhu

Daniel J Vis

Martin Sjöström

Raunak Shrestha

Jeroen Kneppers

...

2024/2/1

Transcriptomic heterogeneity of expansile cribriform and other Gleason Pattern 4 prostate cancer subtypes

European Urology Oncology

Meera R Chappidi

Martin Sjöström

Nancy Y Greenland

Janet E Cowan

Avi S Baskin

...

2024/4/1

Association of a prostate cancer gastrointestinal transcriptional phenotype as found in clinical mCRPC samples with response to AR-targeted therapy.

Aishwarya Subramanian

Meng Zhang

Marina Nasrin Sharifi

Thaidy Moreno Rodriguez

Eric Feng

...

2024/2/1

Gene networks reveal stem-cell state convergence during preneoplasia and progression to malignancy in multistage skin carcinogenesis

bioRxiv

Mark A Taylor

Eve Kandyba

Kyle Halliwill

Reyno Delrosario

Matvei Koroshkin

...

2023/5/10

Abstract A062: Alternative promoter usage is linked to transcriptional and epigenetic alterations during prostate cancer progression

Cancer Research

Meng Zhang

Martin Sjöström

Raunak Shrestha

Arian Lundberg

Thaidy Moreno-Rodriguez

...

2023/6/2

Fragmentomic analysis of circulating tumor DNA-targeted cancer panels

Annals of Oncology

KT Helzer

MN Sharifi

JM Sperger

Y Shi

M Annala

...

2023/9/1

Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer

JCI insight

Erolcan Sayar

Radhika A Patel

Ilsa M Coleman

Martine P Roudier

Ailin Zhang

...

2023/4/4

Abstract PR003: Convergent evolution in DNA repair-deficient mCRPC in response to targeted therapy

Cancer Research

Thaidy Moreno

Meng Zhang

Arian Lundberg

Raunak Shrestha

Martin Sjöström

...

2023/6/2

The genomic and epigenomic landscape of double-negative metastatic prostate cancer

Cancer Research

Arian Lundberg

Meng Zhang

Rahul Aggarwal

Haolong Li

Li Zhang

...

2023/8/15

AR inhibition increases MHC class I expression and improves immune response in prostate cancer

Lisa N Chesner

Julie N Graff

Fanny Polesso

Alexis Smith

Arian Lundberg

...

2023

Abstract B066: Genome-wide CRISPR screens identify PTGES3 as a druggable AR modulator

Cancer Research

Haolong Li

James E Melnyk

Becky Xu Hua Fu

Siyu Feng

Martin Sjöström

...

2023/6/2

AARDVARK: an automated reversion detector for variants affecting resistance kinetics

Bioinformatics

Thaidy Moreno

Joaquin Magana

David A Quigley

2023/8/1

Abstract A029: Whole genome and transcriptome analysis of paired metastatic biopsies identified resistance mechanisms in castration-resistant prostate cancer

Cancer Research

Xiaolin Zhu

Daniël Vis

Martin Sjöström

Raunak Shrestha

Jeroen Kneppers

...

2023/6/2

Abstract B012: Genomic and epigenomic drivers of double-negative metastatic prostate cancer

Cancer Research

Arian Lundberg

Meng Zhang

Rahul R Aggarwal

Haolong Li

Li Zhang

...

2023/6/2

Abstract B041: AR suppresses MHC Class I expression and T-cell response in prostate cancer

Cancer Research

Lisa Chesner

Julie Graff

Fanny Polesso

Alexis Smith

Arian Lundberg

...

2023/6/2

Abstract B031: Investigation of the ubiquitin ligase RNF31 as a mediator of immune evasion in advanced prostate cancer

Cancer Research

Tianyi Liu

Haolong Li

Tony Junjie Hua

Hyunjin Shin

Tanushree Shenoy

...

2023/6/2

See List of Professors in David Quigley University(University of California, San Francisco)